Senseonics reports Q3 loss, 140% revenue jump and raises FY 2026 outlook
+3 new sources since this summary was written
Senseonics Holdings posted Q3 2026 GAAP EPS of -$0.50, beating estimates by $0.02, and revenue of $19.6 million, a 140% year‑over‑year increase. Net loss widened to $32.7 million and gross margin improved to about 62%. The company lifted its full‑year 2026 revenue guidance to $68 million‑$70 million and raised its gross‑margin outlook to above 60%, while announcing a partnership with Beta Bionics and the start of human testing for its Freedom CGM system.
Why it matters
The higher revenue and margin guidance suggest a faster path to profitability, which could support a re‑rating of the stock (the company’s own guidance and the press release note the outlook). The guidance lift also triggered a pre‑market price jump of roughly 15‑18% as reported by multiple outlets.
Key facts
- 1Q3 revenue was $19.6 million, up approximately 140% year over year from $8.1 million in Q3 2025. rttnews.com
- 2GAAP EPS was -$0.50, beating analyst estimates by $0.02. seekingalpha.com
- 3Net loss widened to $32.7 million, or $0.50 per share, versus $19.5 million, or $0.43 per share, in the prior-year quarter. rttnews.com
- 4Gross profit was $12.1 million, giving a gross margin of approximately 62%, up from 43% a year earlier. rttnews.com
- 5Full‑year 2026 revenue guidance was raised to $68 million‑$70 million, from the prior $62 million‑$66 million range. rttnews.com
- 6Full‑year gross‑margin outlook was increased to more than 60%, up from the earlier 58%‑61% range. rttnews.com
Open questions
- Material 1 reports revenue growth of 142.3% YoY, while material 6 reports a 140% YoY increase.
Summary written by AlphAI AI Desk from 7 of 7 sources. Not investment advice. Figures are as stated by the linked sources.